Non-selective beta-blockers in cirrhosis: Current concepts and controversies

doi:10.5497/wjp.v5.i1.15

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (15152)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

1137

WORD

435

HTML

8141

Figures (1-3)

226

Tables (1-3)

191

Sum=10130

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

1086

Download

1734

Sum=2820

Publishing Process of This Article

Item

Count

Browse

934

Download

1268

Sum=2202

Mar 9, 2016 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Pharmacology

ISSN

2220-3192

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Pharmacol. Mar 9, 2016; 5(1): 15-31
Published online Mar 9, 2016. doi: 10.5497/wjp.v5.i1.15

Full Size Figure Download Figure

Figure 3 Proposed algorithm of Non-selective beta-blocker usage based on current guidelines and recent papers. NSBB: Non-selective beta-blocker; GI: Gastrointestinal; SBP: Spontaneous bacterial peritonitis.

Citation: Rajoriya N, Tripathi D. Non-selective beta-blockers in cirrhosis: Current concepts and controversies. World J Pharmacol 2016; 5(1): 15-31
URL: https://www.wjgnet.com/2220-3192/full/v5/i1/15.htm
DOI: https://dx.doi.org/10.5497/wjp.v5.i1.15